Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Health and Happiness (H&H) International Holdings Limited (1112.HK)
Quarry Bay, HK
As an investment holding entity, Health and Happiness (H&H) International Holdings Limited specializes in the global production and distribution of nutritional and care products designed for families and infants. Its offerings are categorized into several key segments. The Infant Formulas division crafts nutritional formulas for children up to age seven, alongside specialized milk products for pregnant and breastfeeding women. The Probiotic Supplements division provides various forms of probiotics, including sachets, capsules, and tablets, catering to the needs of babies, children, and expecting mothers. Within its Adult Nutrition and Care Products segment, H&H develops and markets a range of items such as vitamins, general health supplements, skincare solutions, and sports nutrition for grown-ups. Complementing its infant offerings, the Other Pediatric Products segment focuses on manufacturing dried baby foods, additional nutritional supplements, and general baby care items. Furthermore, its Pet Nutrition and Care segment creates pet food, health-enhancing supplements, and bone broth products for animals. Beyond these core product lines, the company's activities extend to research, development, and processing of diverse ingredients like meat, fruit, and vegetable powders, as well as candies. It actively researches, develops, manufactures, and sells specialized nutritional foods, manages the marketing and distribution of organic baby foods, and handles the wholesale, retail, import, and export of infant nutritional and personal care products. H&H also engages in the trading and sale of adult vitamins, health supplements, probiotic skincare, and sports nutrition items, while offering online sales platforms, software and IT solutions, and packaging services. Its extensive product portfolio is marketed under well-known brands such as Biostime, Swisse, Aurelia, Zesty Paws, Solid Gold, Dodie, Good Gout, Aurelia London, and CBII. Established in 1999, the company adopted its current name, Health and Happiness (H&H) International Holdings Limited, in June 2017, having previously operated as Biostime International Holdings Limited. Headquartered in Quarry Bay, Hong Kong, H&H functions as a subsidiary of Biostime Pharmaceuticals (China) Limited.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.41% | -1.69% | -15.35% | -18.73% | -16.45% | -7.09% | -5.50% | +11.83% | -61.67% | -48.02% | +17.21% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 6 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Packaged Foods: +4.4%+10.0% ★ Q4'25: +5.6% (vs Q4'23)
-
EPS growth Packaged Foods: +14.6%+469.9% ★ Q4'25: +593.8% (vs Q4'23)
-
FCF margin FCF growth · Packaged Foods: +15.9%+1.3% Q4'25: +3.2% (vs Q4'23)
-
EBIT margin Packaged Foods: +7.9%+10.9% ★ Q4'25: +8.8% (vs Q4'23)
-
ROIC Packaged Foods: +7.0%+7.0% ★ Q4'25: +11.7% (vs Q4'23)
-
Share dilution Packaged Foods: +0.0%+0.1% Q4'25: -0.7% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Packaged Foods: 0.19×5.10× Q4'25: 3.09× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2010 actual |
Dec 2011 actual |
Dec 2012 actual |
Dec 2013 actual |
Dec 2014 actual |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 8 Rev. Ana. 6 EPS Ana. |
Dec 2027 8 Rev. Ana. 6 EPS Ana. |
Dec 2028 6 Rev. Ana. 5 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
1.23B
est: 1.21B (+2.2%)
|
2.19B
est: 2.05B (+6.5%)
|
3.38B
est: 3.17B (+6.8%)
|
4.56B
est: 4.87B (-6.4%)
|
4.73B
est: 4.68B (+1.2%)
|
4.82B
est: 5.55B (-13.1%)
|
6.51B
est: 7.16B (-9.1%)
|
8.10B
est: 9.46B (-14.4%)
|
10.13B
est: 11.66B (-13.1%)
|
10.93B
est: 11.98B (-8.8%)
|
11.19B
est: 13.57B (-17.5%)
|
11.55B
est: 14.32B (-19.4%)
|
12.78B
est: 14.46B (-11.7%)
|
13.93B
est: 12.69B (+9.8%)
|
13.05B
est: 13.08B (-0.2%)
|
14.35B
est: 14.30B (+0.4%)
|
16.61B
15.96B – 17.00B
+16.2% YoY
|
18.23B
17.20B – 19.10B
+9.8% YoY
|
19.92B
18.96B – 20.63B
+9.3% YoY
|
| EBITDA |
341.13M
est: 171.74M (+98.6%)
|
726.89M
est: 580.57M (+25.2%)
|
1.08B
est: 1.14B (-5.3%)
|
1.36B
est: 1.65B (-17.3%)
|
1.26B
est: 1.13B (+11.1%)
|
745.14M
est: 1.07B (-30.5%)
|
1.87B
est: 549.69M (+239.4%)
|
2.07B
est: 1.39B (+48.8%)
|
2.12B
est: 1.50B (+41.2%)
|
2.18B
est: 1.33B (+63.7%)
|
2.13B
est: 1.56B (+37.0%)
|
1.42B
est: 1.70B (-16.7%)
|
1.87B
est: 1.92B (-2.4%)
|
2.04B
est: 1.64B (+24.9%)
|
1.37B
est: 1.72B (-20.3%)
|
1.78B
est: 1.84B (-3.6%)
|
2.14B
2.06B – 2.19B
+16.2% YoY
|
2.35B
2.22B – 2.46B
+9.8% YoY
|
2.57B
2.45B – 2.66B
+9.3% YoY
|
| EBIT |
334.06M
est: 142.54M (+134.4%)
|
713.91M
est: 568.65M (+25.5%)
|
1.05B
est: 1.12B (-5.6%)
|
1.17B
est: 1.62B (-27.6%)
|
1.21B
est: 1.13B (+7.0%)
|
656.77M
est: 1.19B (-45.0%)
|
1.85B
est: 918.31M (+101.9%)
|
1.83B
est: 2.36B (-22.4%)
|
1.94B
est: 2.40B (-19.0%)
|
1.93B
est: 2.10B (-8.3%)
|
1.85B
est: 2.05B (-9.6%)
|
1.11B
est: 2.24B (-50.2%)
|
1.56B
est: 2.52B (-38.1%)
|
1.74B
est: 1.36B (+28.5%)
|
1.07B
est: 1.42B (-25.0%)
|
1.56B
est: 1.53B (+2.1%)
|
1.77B
1.71B – 1.82B
+16.2% YoY
|
1.95B
1.84B – 2.04B
+9.8% YoY
|
2.13B
2.03B – 2.20B
+9.3% YoY
|
| Net Income |
265.68M
est: 219.19M (+21.2%)
|
527.35M
est: 452.88M (+16.4%)
|
743.11M
est: 823.41M (-9.8%)
|
820.72M
est: 1.14B (-28.2%)
|
806.79M
est: 788.09M (+2.4%)
|
251.46M
est: 799.81M (-68.6%)
|
954.40M
est: 350.31M (+172.4%)
|
932.85M
est: 1.18B (-20.8%)
|
843.15M
est: 1.22B (-30.6%)
|
1.01B
est: 897.69M (+12.0%)
|
1.14B
est: 1.07B (+6.4%)
|
508.48M
est: 1.17B (-56.5%)
|
611.78M
est: 744.68M (-17.8%)
|
581.85M
est: 260.12M (+123.7%)
|
-53.72M
est: 577.04M (-109.3%)
|
196.14M
est: 599.57M (-67.3%)
|
744.58M
702.55M – 786.62M
+24.2% YoY
|
927.23M
870.46M – 983.99M
+24.5% YoY
|
1.20B
1.04B – 1.36B
+29.9% YoY
|
| SGA |
537.09M
est: 573.95M (-6.4%)
|
790.65M
est: 914.26M (-13.5%)
|
1.19B
est: 1.24B (-3.3%)
|
1.69B
est: 1.84B (-8.0%)
|
1.76B
est: 1.62B (+8.7%)
|
2.26B
est: 1.75B (+29.1%)
|
2.31B
est: 3.16B (-26.9%)
|
3.20B
est: 2.86B (+11.7%)
|
4.32B
est: 4.16B (+3.9%)
|
5.13B
est: 4.60B (+11.5%)
|
5.28B
est: 5.46B (-3.2%)
|
5.67B
est: 5.98B (-5.2%)
|
5.96B
est: 6.73B (-11.4%)
|
6.43B
est: 6.09B (+5.7%)
|
6.35B
est: 6.39B (-0.6%)
|
7.08B
est: 6.86B (+3.2%)
|
7.97B
7.66B – 8.16B
+16.2% YoY
|
8.75B
8.25B – 9.16B
+9.8% YoY
|
9.56B
9.10B – 9.90B
+9.3% YoY
|
| EPS |
0.58
est: 0.34 (+69.7%)
|
0.88
est: 0.60 (+45.8%)
|
1.24
est: 0.93 (+33.9%)
|
1.37
est: 1.34 (+2.2%)
|
1.34
est: 0.87 (+53.7%)
|
0.41
est: 0.23 (+81.0%)
|
1.52
est: 0.97 (+56.4%)
|
1.48
est: 1.49 (-0.5%)
|
1.32
est: 1.80 (-26.8%)
|
1.57
est: 1.65 (-4.8%)
|
1.77
est: 1.76 (+0.7%)
|
0.79
est: 1.51 (-47.7%)
|
0.96
est: 1.13 (-14.9%)
|
0.90
est: 0.41 (+121.7%)
|
-0.08
est: 0.91 (-109.2%)
|
0.31
est: 0.94 (-66.9%)
|
1.14
1.09 – 1.23
+21.8% YoY
|
1.46
1.36 – 1.53
+28.1% YoY
|
1.78
1.63 – 2.12
+21.9% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B | 3/5 | 5/5 | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-28 | B | 3/5 | 5/5 | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-27 | B | 3/5 | 5/5 | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-26 | B | 3/5 | 5/5 | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-22 | B | 3/5 | 5/5 | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-21 | B | 3/5 | 5/5 | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-20 | B | 3/5 | 5/5 | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-19 | B | 3/5 | 5/5 | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-18 | B | 3/5 | 5/5 | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-15 | B | 3/5 | 5/5 | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-14 | B | 3/5 | 5/5 | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-13 | B | 3/5 | 5/5 | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-12 | B | 3/5 | 5/5 | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-11 | B | 3/5 | 5/5 | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-08 | B | 3/5 | 5/5 | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-07 | B | 3/5 | 5/5 | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-06 | B | 3/5 | 5/5 | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-05 | B | 3/5 | 5/5 | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-04 | B | 3/5 | 5/5 | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-30 | B | 3/5 | 5/5 | 2/5 | 3/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-29 | B | 3/5 | 5/5 | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-28 | B | 3/5 | 5/5 | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-27 | B | 3/5 | 5/5 | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-24 | B | 3/5 | 5/5 | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-23 | B+ | 3/5 | 5/5 | 2/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-22 | B+ | 3/5 | 5/5 | 2/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-21 | B+ | 3/5 | 5/5 | 2/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-20 | B+ | 3/5 | 5/5 | 2/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-17 | B+ | 3/5 | 5/5 | 2/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-16 | B+ | 3/5 | 5/5 | 2/5 | 4/5 | 1/5 | 2/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | FlexShares Morningstar Emerging Markets Factor Tilt Index Fund TLTE | 0.04% | 152.7K | 0.58% |
| 2 | State Street SPDR S&P Emerging Markets Small Cap ETF EWX | 0.04% | 251.3K | 0.65% |
| 3 | iShares MSCI AC Far East ex-Japan Small Cap UCITS ETF ISFE.L | 0.03% | 24.6K | 0.74% |
| 4 | iShares $ Treasury Bond 3-7yr UCITS ETF CBUG.DE | 0.02% | 84.5K | 0.10% |
| 5 | UBS MSCI World Small Cap Socially Responsible UCITS ETF USD dis WSCR.L | 0.01% | 119.8K | 0.23% |
| 6 | UBS MSCI World Small Cap Socially Responsible UCITS ETF USD acc WSCSRI.SW | 0.01% | 119.9K | 0.23% |
| 7 | iShares Currency Hedged MSCI EAFE Small-Cap ETF HSCZ | 0.01% | 25.6K | 0.83% |
| 8 | iShares MSCI EAFE Small-Cap ETF SCZ | 0.01% | 1.55M | 0.40% |
| 9 | Dimensional Emerging Markets Sustainability Core 1 ETF DFSE | 0.01% | 69.5K | 0.44% |
| 10 | State Street SPDR S&P China ETF GXC | 0.01% | 43.0K | 0.59% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Yidong Wang | Chief Financial Officer & Executive Director | 13M | male |
| Fei Luo | Executive Chairman of the Board | 4M | male |
| Fengting Li | Chief Executive Officer for China | — | female |
| Johannes Jacobus Cappon | Chief Technology Officer | — | — |
| Akash Bedi | Chief Executive Officer & CEO of Europe, North America, Middle East and India | — | male |
| Pascale Laborde | Chief Growth & Sustainability Officer and Director of Global Marketing and Communications | — | female |
| Qizhang Zhang | Chief People Officer | — | male |
| Wenyun Yang | Senior Director of the Listing Affairs & Risk Management Department and Company Secretary | — | female |
| Nicholas Russell Lamande Mann | Chief Executive Officer for Asia, Australia & New Zealand | — | male |
| Christian Sim | Chief Supply Chain Officer | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 1112.HK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
